RHI Magnesita India Ltd
RHI Magnestia India ltd earlier known as Orient Refractories Limited (ORL) is in the business of manufacturing and marketing special refractory products, systems
and services to the steel industry in India and Globally. It is a market leader for special refractories in India and has many global customers for its international quality products.[1]
- Market Cap ₹ 8,963 Cr.
- Current Price ₹ 435
- High / Low ₹ 548 / 376
- Stock P/E 49.7
- Book Value ₹ 199
- Dividend Yield 0.57 %
- ROCE 7.71 %
- ROE 5.62 %
- Face Value ₹ 1.00
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Company has a low return on equity of -0.39% over last 3 years.
- Promoter holding has decreased over last 3 years: -14.1%
- Working capital days have increased from 90.2 days to 140 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 403 | 451 | 459 | 519 | 628 | 748 | 696 | 1,366 | 1,991 | 2,488 | 2,824 | 2,892 | 3,197 | |
| 324 | 371 | 374 | 415 | 500 | 619 | 574 | 1,158 | 1,607 | 2,121 | 2,395 | 2,506 | 2,869 | |
| Operating Profit | 79 | 81 | 85 | 104 | 128 | 129 | 122 | 208 | 384 | 367 | 429 | 386 | 329 |
| OPM % | 20% | 18% | 19% | 20% | 20% | 17% | 18% | 15% | 19% | 15% | 15% | 13% | 10% |
| 4 | 5 | 5 | 8 | 10 | 18 | 6 | 12 | 9 | -649 | -309 | 3 | 2 | |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 7 | 3 | 21 | 17 | 11 | 8 |
| Depreciation | 4 | 5 | 6 | 6 | 7 | 9 | 11 | 30 | 34 | 42 | 68 | 77 | 79 |
| Profit before tax | 80 | 80 | 85 | 105 | 131 | 138 | 117 | 184 | 356 | -345 | 34 | 301 | 244 |
| Tax % | 34% | 34% | 34% | 35% | 34% | 35% | 25% | 26% | 25% | 24% | 261% | 26% | |
| 53 | 53 | 56 | 69 | 86 | 90 | 87 | 136 | 268 | -427 | -55 | 223 | 180 | |
| EPS in Rs | 4.40 | 4.40 | 4.65 | 5.74 | 7.14 | 7.48 | 7.26 | 11.32 | 16.64 | -22.70 | -2.68 | 10.80 | 8.73 |
| Dividend Payout % | 28% | 32% | 31% | 44% | 35% | 33% | 34% | 22% | 15% | -11% | -93% | 23% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 33% |
| 3 Years: | 13% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 21% |
| 3 Years: | -6% |
| TTM: | -22% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 13% |
| 3 Years: | -17% |
| 1 Year: | -10% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 3% |
| 3 Years: | 0% |
| Last Year: | 6% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 16 | 19 | 21 | 21 | 21 |
| Reserves | 126 | 158 | 193 | 261 | 311 | 364 | 415 | 793 | 1,011 | 2,910 | 3,881 | 4,055 | 4,091 |
| 6 | 5 | 0 | 0 | 0 | 0 | 0 | 62 | 65 | 618 | 111 | 45 | 64 | |
| 74 | 79 | 101 | 87 | 126 | 132 | 152 | 391 | 580 | 890 | 610 | 620 | 792 | |
| Total Liabilities | 218 | 254 | 306 | 360 | 449 | 508 | 579 | 1,259 | 1,672 | 4,436 | 4,623 | 4,740 | 4,967 |
| 30 | 33 | 38 | 37 | 40 | 60 | 129 | 239 | 278 | 1,030 | 1,021 | 1,016 | 1,041 | |
| CWIP | 2 | 4 | 2 | 5 | 14 | 3 | 4 | 46 | 34 | 27 | 34 | 50 | 44 |
| Investments | 0 | 0 | 0 | 0 | 108 | 103 | 10 | 10 | 10 | 1,718 | 1,865 | 1,865 | 1,867 |
| 186 | 216 | 266 | 318 | 287 | 342 | 436 | 964 | 1,350 | 1,661 | 1,703 | 1,810 | 2,015 | |
| Total Assets | 218 | 254 | 306 | 360 | 449 | 508 | 579 | 1,259 | 1,672 | 4,436 | 4,623 | 4,740 | 4,967 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29 | 34 | 80 | 60 | 57 | 54 | 97 | 166 | 26 | 351 | 87 | 259 | |
| -2 | -10 | -4 | -6 | -121 | -5 | 27 | -78 | -71 | -768 | -650 | -85 | |
| -13 | -18 | -25 | -20 | -35 | -35 | -36 | -55 | -50 | 481 | 476 | -135 | |
| Net Cash Flow | 14 | 7 | 51 | 34 | -99 | 14 | 88 | 33 | -95 | 64 | -87 | 39 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 90 | 91 | 94 | 80 | 93 | 77 | 77 | 87 | 90 | 75 | 91 | 77 |
| Inventory Days | 108 | 104 | 92 | 102 | 96 | 96 | 116 | 151 | 186 | 147 | 129 | 155 |
| Days Payable | 87 | 75 | 103 | 97 | 105 | 92 | 111 | 149 | 161 | 149 | 103 | 107 |
| Cash Conversion Cycle | 111 | 120 | 83 | 85 | 84 | 82 | 81 | 90 | 114 | 72 | 117 | 125 |
| Working Capital Days | 80 | 86 | 71 | 81 | 82 | 87 | 87 | 108 | 120 | 5 | 126 | 140 |
| ROCE % | 64% | 50% | 44% | 44% | 44% | 40% | 29% | 29% | 37% | 15% | 10% | 8% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
30 Jan - RHIM7 merged into RHIMIRL; appointed date 01-Apr-2025; confirmation received 30-Jan-2026; turnovers Rs87,370.72L and Rs12,726.25L.
-
Board Meeting Intimation for Inter Alia, To Consider, Approve And Take On Record The Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter And Nine Months Ended 31 December 2025
30 Jan - Board meets 13 Feb 2026 to approve Q3/9M Dec 31, 2025 results; trading window closed until 15 Feb 2026.
-
Announcement under Regulation 30 (LODR)-Change in Directorate
14 Jan - Alvaro Martin Rivero appointed Additional Director effective 14 January 2026; Board committees reconstituted.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 12 Jan
-
Closure of Trading Window
29 Dec 2025 - Trading window closed from 1 Jan 2026 until 48 hours after Q3/9M results for period ended 31 Dec 2025.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from nse
Concalls
-
Nov 2025Transcript PPT
-
Aug 2025Transcript PPT REC
-
Jun 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
Aug 2024TranscriptAI SummaryPPT
-
Jun 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT REC
-
Feb 2023Transcript PPT
-
Feb 2023TranscriptAI SummaryPPT
-
Aug 2022TranscriptAI SummaryPPT
-
Aug 2022TranscriptAI SummaryPPT
Market Leadership
The company is the leading global manufacturer and supplier of high-grade refractory products, systems, and solutions with a 30% market share in India. [1]